Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07324850
Eligibility Criteria:
Inclusion Criteria:
* Body Mass Index (BMI) within the range of 26.0 to 35.0 kg/m²
* Have a stable body weight within 3 months
* Participants must agree to use adequate contraception from signing the informed consent until 6 months after completion of the follow-up visit.
* Willing to comply with the protocol required visit schedule and visit requirements and provide written informed consent.
Exclusion Criteria:
* A history of or a current surgical or medical condition that, in the opinion of the Investigator, may put the subject at significant risk (according to Investigator's judgment) or interfere with the subject's participation in the clinical study.
* Use of GLP-1R agonists for any indication within 6 months prior to administering the investigational drug.
* Use of non-GLP1R medications for weight loss within 3 months prior to administering the investigational drug.
* Alanine aminotransferase (ALT), total bilirubin (TBIL), aspartate aminotransferase (AST)\> 1.5 × ULN, and deemed clinically significant by the Investigators
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT07324850
Study Brief:
Protocol Section:
NCT07324850